Cargando…
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection
We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutra...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769986/ https://www.ncbi.nlm.nih.gov/pubmed/36374040 http://dx.doi.org/10.1128/spectrum.01837-22 |
_version_ | 1784854493611950080 |
---|---|
author | Vangeti, Sindhu Periasamy, Sivakumar Sun, Peifang Balinsky, Corey A. Mahajan, Avinash S. Kuzmina, Natalia A. Soares-Schanoski, Alessandra Cooper, Elizabeth Beckett, Charmagne Marayag, Jan Marrone, Amethyst Nunez, Edgar Ge, Yongchao Porter, Chad K. Goforth, Carl W. Lizewski, Stephen E. Lizewski, Rhonda Jani, Vihasi Sugiharto, Victor A. Schilling, Megan Yu, Xuechen B. Marjanovic, Nada George, Mary Catherine Bukreyev, Alexander Sealfon, Stuart C. Letizia, Andrew G. Ramos, Irene |
author_facet | Vangeti, Sindhu Periasamy, Sivakumar Sun, Peifang Balinsky, Corey A. Mahajan, Avinash S. Kuzmina, Natalia A. Soares-Schanoski, Alessandra Cooper, Elizabeth Beckett, Charmagne Marayag, Jan Marrone, Amethyst Nunez, Edgar Ge, Yongchao Porter, Chad K. Goforth, Carl W. Lizewski, Stephen E. Lizewski, Rhonda Jani, Vihasi Sugiharto, Victor A. Schilling, Megan Yu, Xuechen B. Marjanovic, Nada George, Mary Catherine Bukreyev, Alexander Sealfon, Stuart C. Letizia, Andrew G. Ramos, Irene |
author_sort | Vangeti, Sindhu |
collection | PubMed |
description | We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutralization antibody titers from early (11 to 56 days) to late (4 to 8.5 months) time points postinfection. Over the study period, S1-specific IgG levels declined significantly faster than that of the S2-specific IgG. Further, serum antibodies from PCR-confirmed participants cross-recognized S2, but not S1, of the betacoronaviruses HKU1 and OC43, suggesting a greater degree of cross-reactivity of S2 among betacoronaviruses. Antibody-Dependent Natural Killer cell Activation (ADNKA) was detected at the early time point but significantly decreased at the late time point. Induction of serum Antibody-Dependent Monocyte Phagocytosis (ADMP) was detected in all the infected participants, and its levels remained stable over time. Additionally, a reduced percentage of participants had detectable neutralizing activity against the Beta (50%), Gamma (61 to 67%), and Delta (90 to 94%) variants, both early and late postinfection, compared to the ancestral strain (100%). Antibody binding to S1 and RBD of Beta, Gamma, Delta (1.7 to 2.3-fold decrease), and Omicron (10 to 16-fold decrease) variants was also significantly reduced compared to the ancestral SARS-CoV-2 strain. Overall, we found variable temporal profiles of specific components and functionality of the serological response to SARS-CoV-2 in young adults, which is characterized by lasting, but decreased, neutralizing activity and antibody binding to S1, stable ADMP activity, and relatively stable S2-specific IgG levels. IMPORTANCE Adaptive immunity mediated by antibodies is important for controlling SARS-CoV-2 infection. While vaccines against COVID-19 are currently widely distributed, a high proportion of the global population is still unvaccinated. Therefore, understanding the dynamics and maintenance of the naive humoral immune response to SARS-CoV-2 is of great importance. In addition, long-term responses after asymptomatic infection are not well-characterized, given the challenges in identifying such cases. Here, we investigated the longitudinal humoral profile in a well-characterized cohort of young adults with documented asymptomatic or mildly symptomatic SARS-CoV-2 infection. By analyzing samples collected preinfection, early after infection and during late convalescence, we found that, while neutralizing activity decreased over time, high levels of serum S2 IgG and Antibody-Dependent Monocyte Phagocytosis (ADMP) activity were maintained up to 8.5 months after infection. This suggests that a subset of antibodies with specific functions could contribute to long-term protection against SARS-CoV-2 in convalescent unvaccinated individuals. |
format | Online Article Text |
id | pubmed-9769986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-97699862022-12-22 Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection Vangeti, Sindhu Periasamy, Sivakumar Sun, Peifang Balinsky, Corey A. Mahajan, Avinash S. Kuzmina, Natalia A. Soares-Schanoski, Alessandra Cooper, Elizabeth Beckett, Charmagne Marayag, Jan Marrone, Amethyst Nunez, Edgar Ge, Yongchao Porter, Chad K. Goforth, Carl W. Lizewski, Stephen E. Lizewski, Rhonda Jani, Vihasi Sugiharto, Victor A. Schilling, Megan Yu, Xuechen B. Marjanovic, Nada George, Mary Catherine Bukreyev, Alexander Sealfon, Stuart C. Letizia, Andrew G. Ramos, Irene Microbiol Spectr Research Article We investigated the temporal profile of multiple components of the serological response after asymptomatic or mildly symptomatic SARS-CoV-2 infection, in a cohort of 67 previously SARS-CoV-2 naive young adults, up to 8.5 months after infection. We found a significant decrease of spike IgG and neutralization antibody titers from early (11 to 56 days) to late (4 to 8.5 months) time points postinfection. Over the study period, S1-specific IgG levels declined significantly faster than that of the S2-specific IgG. Further, serum antibodies from PCR-confirmed participants cross-recognized S2, but not S1, of the betacoronaviruses HKU1 and OC43, suggesting a greater degree of cross-reactivity of S2 among betacoronaviruses. Antibody-Dependent Natural Killer cell Activation (ADNKA) was detected at the early time point but significantly decreased at the late time point. Induction of serum Antibody-Dependent Monocyte Phagocytosis (ADMP) was detected in all the infected participants, and its levels remained stable over time. Additionally, a reduced percentage of participants had detectable neutralizing activity against the Beta (50%), Gamma (61 to 67%), and Delta (90 to 94%) variants, both early and late postinfection, compared to the ancestral strain (100%). Antibody binding to S1 and RBD of Beta, Gamma, Delta (1.7 to 2.3-fold decrease), and Omicron (10 to 16-fold decrease) variants was also significantly reduced compared to the ancestral SARS-CoV-2 strain. Overall, we found variable temporal profiles of specific components and functionality of the serological response to SARS-CoV-2 in young adults, which is characterized by lasting, but decreased, neutralizing activity and antibody binding to S1, stable ADMP activity, and relatively stable S2-specific IgG levels. IMPORTANCE Adaptive immunity mediated by antibodies is important for controlling SARS-CoV-2 infection. While vaccines against COVID-19 are currently widely distributed, a high proportion of the global population is still unvaccinated. Therefore, understanding the dynamics and maintenance of the naive humoral immune response to SARS-CoV-2 is of great importance. In addition, long-term responses after asymptomatic infection are not well-characterized, given the challenges in identifying such cases. Here, we investigated the longitudinal humoral profile in a well-characterized cohort of young adults with documented asymptomatic or mildly symptomatic SARS-CoV-2 infection. By analyzing samples collected preinfection, early after infection and during late convalescence, we found that, while neutralizing activity decreased over time, high levels of serum S2 IgG and Antibody-Dependent Monocyte Phagocytosis (ADMP) activity were maintained up to 8.5 months after infection. This suggests that a subset of antibodies with specific functions could contribute to long-term protection against SARS-CoV-2 in convalescent unvaccinated individuals. American Society for Microbiology 2022-11-14 /pmc/articles/PMC9769986/ /pubmed/36374040 http://dx.doi.org/10.1128/spectrum.01837-22 Text en https://doi.org/10.1128/AuthorWarrantyLicense.v1This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. |
spellingShingle | Research Article Vangeti, Sindhu Periasamy, Sivakumar Sun, Peifang Balinsky, Corey A. Mahajan, Avinash S. Kuzmina, Natalia A. Soares-Schanoski, Alessandra Cooper, Elizabeth Beckett, Charmagne Marayag, Jan Marrone, Amethyst Nunez, Edgar Ge, Yongchao Porter, Chad K. Goforth, Carl W. Lizewski, Stephen E. Lizewski, Rhonda Jani, Vihasi Sugiharto, Victor A. Schilling, Megan Yu, Xuechen B. Marjanovic, Nada George, Mary Catherine Bukreyev, Alexander Sealfon, Stuart C. Letizia, Andrew G. Ramos, Irene Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection |
title | Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection |
title_full | Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection |
title_fullStr | Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection |
title_full_unstemmed | Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection |
title_short | Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection |
title_sort | serum fc-mediated monocyte phagocytosis activity is stable for several months after sars-cov-2 asymptomatic and mildly symptomatic infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769986/ https://www.ncbi.nlm.nih.gov/pubmed/36374040 http://dx.doi.org/10.1128/spectrum.01837-22 |
work_keys_str_mv | AT vangetisindhu serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT periasamysivakumar serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT sunpeifang serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT balinskycoreya serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT mahajanavinashs serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT kuzminanataliaa serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT soaresschanoskialessandra serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT cooperelizabeth serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT beckettcharmagne serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT marayagjan serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT marroneamethyst serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT nunezedgar serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT geyongchao serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT porterchadk serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT goforthcarlw serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT lizewskistephene serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT lizewskirhonda serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT janivihasi serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT sugihartovictora serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT schillingmegan serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT yuxuechenb serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT marjanovicnada serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT georgemarycatherine serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT bukreyevalexander serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT sealfonstuartc serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT letiziaandrewg serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection AT ramosirene serumfcmediatedmonocytephagocytosisactivityisstableforseveralmonthsaftersarscov2asymptomaticandmildlysymptomaticinfection |